Last edition
News about Outsourcing
Indian Pharma Faces Limited Impact from US Tariffs on Patented Medicines
The announcement by Donald J Trump to impose a 100 Percent tariff on patented pharmaceuticals and their ingredients is expected to have a limited immediate impact on the Indian pharmaceutical industry, according to industry experts.
Outsourcing | 04/04/2026 | By Darshana | 134
New HS 2028 Customs Codes to Boost Global Monitoring of Vaccines and Medical Supplies
The World Health Organization, working in collaboration with the World Trade Organization and the World Customs Organization, has supported an update to the global customs classification system to improve tracking and movement of vaccines and essential medical products.
Outsourcing | 04/02/2026 | By Darshana | 230
Galderma to Spotlight Injectable Aesthetics Innovation at IMCAS 2026 with Ten Scientific Posters
Galderma, the pure-play dermatology category leader with operations in nearly 90 countries, will present ten scientific posters highlighting the latest advances across its injectable aesthetics portfolio at the International Master Course on Aging Science (IMCAS) 2026 World Congress, to be held in Paris, France, from January 29 to 31, 2026.
Outsourcing | 23/01/2026 | By Darshana | 321
Odisha to Host Pharma Summit 2025, Unveil New Pharma and Medical Devices Policy
The summit will bring together pharmaceutical and medical devices manufacturers, startups, innovators, healthcare experts, investors, and other industry stakeholders to explore opportunities within Odisha’s growing pharmaceuticals and healthcare manufacturing sector.
Outsourcing | 15/12/2025 | By Darshana | 405
High-Impact HDV Candidate Drives Mirum's 620 Million USD Acquisition of Bluejay
Mirum Pharmaceuticals, Inc., a leading rare disease company, has entered a definitive agreement to acquire Bluejay Therapeutics, a privately held biotechnology firm focused on viral and liver diseases.
Outsourcing | 09/12/2025 | By Darshana | 206
Nadda Urges Pharma Industry to Cut Reliance on Imported APIs
Health Minister Mansukh Mandaviya has called on India’s pharmaceutical industry to reduce dependency on imported active pharmaceutical ingredients (APIs) and focus on strengthening domestic manufacturing capability. He emphasised that enhancing self-reliance in API production is vital for national health security and economic resilience.
Outsourcing | 21/11/2025 | By Darshana | 208
Olympus Corporation, a global medical technology company dedicated to making lives healthier, safer and more fulfilling, has entered into an exclusive worldwide distribution agreement with MacroLux Medical Technology Co., Ltd. to provide a range of single-use urology products, including cystoscopes, ureteroscopes and suction access sheaths.
Outsourcing | 06/09/2025 | By Darshana | 652
Known for its strong capabilities in biotechnology and respiratory therapeutics manufacturing, Shilpa Medicare—through its biologics arm, Shilpa Biologics—will serve as Alveolus Bio’s exclusive global development and manufacturing partner.
Outsourcing | 07/08/2025 | By Darshana | 317
Advantage eClinical provides a fully integrated suite of data management applications.
Outsourcing | 17/05/2022 | By Content editor | 1560
Glenmark's subsidiary, Ichnos Sciences signs licensing pact with Almirall
Glenmark's 100% subsidiary Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology and autoimmune diseases, and Almirall S.A, a global biopharmaceutical company focused on skin health, announced today that they have entered into an exclusive licensing agreement for the IL-1RAP antagonist ISB 880
Outsourcing | 14/12/2021 | By Darshana | 1571
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy